The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children

Sponsor
Tel-Aviv Sourasky Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00393159
Collaborator
(none)
30
1

Study Details

Study Description

Brief Summary

This study is designed to check the effect of the use of the ear popper device on serous otitis media in children and on the conductive hearing loss accompanying the otitis. It is intended that 30 children aged 3-18 years will participate in the study. The inclusion criteria are : clinical serous otitis media for a duration of more then 3 months, a conductive hearing loss of at least 15 decibels air bone gap and tympanometry type B or C. The children will use the ear popper for 7 weeks. They will undergo otologic examination, audiometry and tympanometry at the beginning ao the trial, at 7 weeks and at 3 months from the beginning of the trial. The otologic findings and the audiometry and tympanometry results before and after the trial will be compared. We will try to determine whether the use of the ear popper in the test group will improve the conductive hearing loss and prevent the need for tympanostomy tube insertion.

Condition or Disease Intervention/Treatment Phase
  • Device: Ear Popper
Phase 4

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
Study Start Date :
Oct 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Audiometry and tympanometry test results at at 7 weeks and 3 months from beginning of use of the ear popper. []

  2. Otoscopic findings at at 7 weeks and 3 months from beginning of use of the ear popper. []

Secondary Outcome Measures

  1. Hearing improvement at 7 weeks and 3 months from the beginning of the trial. []

  2. Rate of referrals for tympanostomy tube insertion at 3 months []

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Serous Otitis Media for More Then 3 months

  • Conductive Hearing Loss of More Then 15 decibels.

  • Tympanometry type B or C.

Exclusion Criteria:
  • No History of Tympanostomy Tube Insertion or Adenoidectomy

  • No Cranio or Facial Malformations

  • No Acute Upper Respiratory Tract Infection or Acute Otitis Media

Contacts and Locations

Locations

Site City State Country Postal Code
1 ENT Unit, Dana Children's Hospital, Tel-Aviv Medical Center Tel-Aviv Israel

Sponsors and Collaborators

  • Tel-Aviv Sourasky Medical Center

Investigators

  • Principal Investigator: Yael Oestreicher, MD, Tel Aviv Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00393159
Other Study ID Numbers:
  • TASMC06YO3567CTIL
First Posted:
Oct 26, 2006
Last Update Posted:
Oct 26, 2006
Last Verified:
Oct 1, 2006

Study Results

No Results Posted as of Oct 26, 2006